Research / CPSH / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-26-006687 General Corporate
Capex intensity 50th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.24% · OPTIONAL · VALID
Operating cash generation 35th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
0.75% · OPTIONAL · VALID
Revenue growth 90th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
54.31% · CORE · VALID
Inventory pressure 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
17.17% · OPTIONAL · VALID
Gross margin 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
16.23% · CORE · VALID
Operating margin 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
1.36% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.66% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.84% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 61 states Self-history eligible
Dec 25, 2021 6/7 normalized Level 3 Apr 2, 2022 6/8 normalized Level 3 Jul 2, 2022 6/8 normalized Level 3 Oct 1, 2022 6/8 normalized Level 3 Dec 31, 2022 6/8 normalized Level 3 Apr 1, 2023 6/8 normalized Level 3 Jul 1, 2023 6/8 normalized Level 3 Sep 30, 2023 6/8 normalized Level 3 Dec 30, 2023 8/8 normalized Level 3 Mar 30, 2024 8/8 normalized Level 3 Dec 30, 2023 8/8 normalized Amended as filed Jun 29, 2024 8/8 normalized Level 3 Sep 28, 2024 8/8 normalized Level 3 Dec 28, 2024 8/8 normalized Level 3 Mar 29, 2025 7/8 normalized Level 3 Jun 28, 2025 7/7 normalized Level 3 Sep 27, 2025 7/8 normalized Level 3 Dec 27, 2025 7/8 normalized Level 3 Mar 28, 2026 7/8 normalized Level 3 Jun 27, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 1.97%
Current 2.24%
Delta 0.27% Cash Generation Decreased
Previous 11.93%
Current 0.75%
Delta -11.18% Growth Decreased
Previous 107.29%
Current 54.31%
Delta -52.97% Inventory Pressure Decreased
Previous 61.15%
Current 17.17%
Delta -43.98% Margin Decreased
Previous 17.07%
Current 16.23%
Delta -0.84% Profitability Decreased
Previous 3.14%
Current 1.36%
Delta -1.77% R And D Intensity Decreased
Previous 10.22%
Current 2.66%
Delta -7.56% Sbc Intensity Increased
Previous 0.56%
Current 0.84%
Delta 0.28% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.